版本:
中国

BRIEF-Anthera announces positive results from the extension period of the solution study of Sollpura

March 29 Anthera Pharmaceuticals Inc

* Anthera announces positive results from the extension period of the solution study of Sollpura

* Anthera -Plans to initiate a phase 3 trial, result in 1H 2017, with topline data anticipated at end of 2017 or early 2018 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐